Data / Form D filings / Renasant Bio, Inc.
Renasant Bio, Inc.: Form D filings
Renasant Bio, Inc., a biotechnology company in Berkeley, CA, filed 2 Form D notices with the SEC in 2025. The latest, on July 14, 2025, reports $30 million sold of a $30 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2630 BANCROFT WAY #507, Berkeley, CA, 94704
- Phone
- (650) 223-5603
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2075979
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 14, 2025 | New notice | $30,000,000 | $30,000,000 | 4 | Jun 3, 2025 | sec.gov | |
| Jul 14, 2025 | New notice | $25,461,184 | $25,461,184 | 3 | Jul 15, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Evan Caplan | Director | |
| Natalie Holles | Director | |
| Charlotte McKee | Director | |
| Deborah Palestrant | Director | |
| Thomas Gustafson | Executive Officer | |
| Anna French | Director | |
| Kevin Bitterman | Director | |
| Emily Conley | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 14, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Renasant Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.